Holen Sie sich die Stockscreener-App
16.07
3.65%
0.565
Schlusskurs vom Vortag:
$15.50
Offen:
$15.34
24-Stunden-Volumen:
36,820
Relative Volume:
0.22
Marktkapitalisierung:
$592.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.25%
1M Leistung:
+29.77%
6M Leistung:
+15.58%
1J Leistung:
-20.59%
1-Tages-Spanne:
$15.20
$16.23
1-Wochen-Bereich:
$14.10
$16.23
52-Wochen-Spanne:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
1325 BOYLSTON STREET, BOSTON
Vergleichen Sie RAPP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
16.23 | 554.76M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.69 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.82 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.14 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
588.61 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.96 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Eingeleitet | Jefferies | Buy |
| 2024-07-02 | Eingeleitet | Stifel | Buy |
| 2024-07-02 | Eingeleitet | TD Cowen | Buy |
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
What drives Rapport Therapeutics Inc. stock priceTremendous return rates - Autocar Professional
Is Rapport Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com
What analysts say about Rapport Therapeutics Inc. stockHigh-impact stock picks - Autocar Professional
Rapport Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com
What drives EOSEW stock priceExceptional gains - Jammu Links News
Top Dividend Stocks in India Expert Trader GroupRapid wealth multiplication - Jammu Links News
What analysts say about Palvella Therapeutics Inc. stockAccelerated capital growth - jammulinksnews.com
What analysts say about Eaton Vance Municipal Income 2028 Term Trust stock outlookSecure Growth Trading Plan - Newser
why rapport therapeutics inc. stock attracts strong analyst attentionFree Exclusive Access to Stock Gurus - Newser
JMP reiterates Market Outperform rating on Rapport Therapeutics stock By Investing.com - Investing.com Canada
Why Rapport Therapeutics Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser
What makes PTC Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Rapport Therapeutics Reports Q1 2025 Financial Results - MSN
Why CRMD stock attracts strong analyst attentionAlpha Stock Ideas - Newser
How High Can MOON(moon coin) GoFree Wealth-Building Investment Strategies - Newser
How Rapport Therapeutics Inc. stock performs during market volatilitySmart Money Signals - Newser
Why Entegris Inc. stock attracts strong analyst attentionVerified Return Tips - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionFree Access to Group - Newser
What makes CIGI stock price move sharplyHigh Return Intraday Picks - Newser
What makes Rapport Therapeutics Inc. stock price move sharplyFree Insider Trading Tips - Newser
How American Water Works Company Inc. stock performs during market volatilityChart Breakout Alert - Newser
What makes IPCXU stock price move sharplyFree Group Entry - Newser
When CLEU stock expected to show significant growthIs SXTC stock a good long term investment optionTriple Return With Stability - Newser
Why SPHL stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser
Leverage AI to enhance your marketing strategy with real time consumer insightsHigh Return Setup Scanner - Newser
Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest
Rapport Therapeutics’ (RAPP) Market Outperform Rating Reiterated at JMP Securities - Defense World
How will RAPP's Q1 2025 earnings forecast impact investors? - AInvest
Rapport Therapeutics, Inc.(NasdaqGM: RAPP) dropped from Russell Microcap Growth Index - MarketScreener
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bredt David | Chief Scientific Officer |
Jun 16 '25 |
Sale |
11.00 |
8,500 |
93,522 |
443,642 |
3.28%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):